DE69826593D1 - Neospora Impstoff - Google Patents

Neospora Impstoff

Info

Publication number
DE69826593D1
DE69826593D1 DE69826593T DE69826593T DE69826593D1 DE 69826593 D1 DE69826593 D1 DE 69826593D1 DE 69826593 T DE69826593 T DE 69826593T DE 69826593 T DE69826593 T DE 69826593T DE 69826593 D1 DE69826593 D1 DE 69826593D1
Authority
DE
Germany
Prior art keywords
neospora vaccine
neospora
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69826593T
Other languages
English (en)
Other versions
DE69826593T2 (de
Inventor
David Alan Brake
Manuel Campos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22007613&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69826593(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Application granted granted Critical
Publication of DE69826593D1 publication Critical patent/DE69826593D1/de
Publication of DE69826593T2 publication Critical patent/DE69826593T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69826593T 1997-08-26 1998-08-12 Neospora Impfstoff Expired - Fee Related DE69826593T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5695697P 1997-08-26 1997-08-26
US56956P 1997-08-26

Publications (2)

Publication Number Publication Date
DE69826593D1 true DE69826593D1 (de) 2004-11-04
DE69826593T2 DE69826593T2 (de) 2005-02-10

Family

ID=22007613

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69826593T Expired - Fee Related DE69826593T2 (de) 1997-08-26 1998-08-12 Neospora Impfstoff

Country Status (16)

Country Link
US (2) US6787146B2 (de)
EP (2) EP1477184A3 (de)
JP (1) JP3049016B2 (de)
CN (1) CN1211449A (de)
AR (1) AR016396A1 (de)
AT (1) ATE277631T1 (de)
AU (1) AU764455B2 (de)
BR (1) BR9803232A (de)
CA (1) CA2245425C (de)
DE (1) DE69826593T2 (de)
DK (1) DK0898969T3 (de)
ES (1) ES2227783T3 (de)
NZ (1) NZ331529A (de)
PT (1) PT898969E (de)
TW (2) TW200305433A (de)
ZA (1) ZA987662B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU745183B2 (en) 1997-10-20 2002-03-14 Bayer Corporation Neospora vaccines
EP0953641A3 (de) * 1998-03-26 2002-03-13 Pfizer Products Inc. Für Neospora Proteine kodierende polynukleotid Moleküle
MXPA05002255A (es) * 2002-08-26 2005-06-08 Pfizer Prod Inc Vacunas para infecciones del sistema respiratorio y reproductor en ganado.
CA2503457A1 (en) * 2002-10-25 2004-05-06 University Of Connecticut Health Center Apparatus and method for immunotherapy of a cancer through controlled cell lysis
WO2005118884A1 (en) * 2004-05-28 2005-12-15 The United States Of America As Represented By The Secretary Of The Navy A method for the rapid diagnosis of infectious disease by detection and quantitation of microorganism induced cytokines
ES2319242B1 (es) 2005-12-23 2009-12-01 Laboratorios Hipra, S.A. Aislado avirulento de neospora canimum y sus usos.
ES2326770B1 (es) 2007-07-13 2010-07-26 Universidad Complutense De Madrid Uso de un nuevo aislado de neospora caninum para el desarrollo de pruebas de diagnostico y para la fabricacion de productos para el tratamiento y prevencion de la infenccion causada por neospora.
CN101831495B (zh) * 2010-04-30 2013-06-19 新疆出入境检验检疫局检验检疫技术中心 一种牛新孢子虫病的检测方法及应用
EP2708237A1 (de) * 2012-09-17 2014-03-19 Université de Droit et de la Santé de Lille 2 Pharmazeutische Zusammensetzung zu deren Verwendung bei der präventiven Behandlung von Infektionen, die durch einen intrazellularen Krankheitserreger, speziell durch Toxoplasma gondii, verursacht werden
EP2994162B1 (de) 2013-05-08 2021-04-07 Pharmgate Biologics Inc. Impfstoff für pcv2 und mycoplasma
ES2960032T3 (es) 2015-10-28 2024-02-29 Univ Madrid Complutense Composición de una vacuna de Neospora
JP2019533995A (ja) 2016-10-05 2019-11-28 ゾエティス・サービシーズ・エルエルシー 強力な生ワクチンとして使用するための安定に脱水された原生動物を提供する凍結乾燥方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643718A (en) * 1993-11-04 1997-07-01 The Board Of Trustees Of The Leland Stanford Junior University Transfection and genetic manipulations in obligate intracellular parasites
US5707617A (en) * 1994-03-21 1998-01-13 The Regents Of The University Of California Bovine neospora isolates
US5889166A (en) * 1996-05-10 1999-03-30 The Regents Of The University Of California Recombinant neospora antigens and their uses
US6743430B1 (en) 1995-03-29 2004-06-01 Richard E. Parizek Multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose
CA2184132C (en) 1995-09-21 2011-03-15 Kristina J. Hennessy An adjuvanted vaccine which is substantially free of non-host albumin
AU7677896A (en) 1995-11-09 1997-05-29 Trustees Of Dartmouth College A vaccine against toxoplasma gondii
EP0841392B1 (de) * 1996-11-12 2004-07-14 Pfizer Inc. Attenuierter lebender Neospora Impfstoff

Also Published As

Publication number Publication date
CA2245425C (en) 2006-12-12
DE69826593T2 (de) 2005-02-10
US6787146B2 (en) 2004-09-07
EP1477184A2 (de) 2004-11-17
ATE277631T1 (de) 2004-10-15
CA2245425A1 (en) 1999-02-26
ES2227783T3 (es) 2005-04-01
US20040223982A1 (en) 2004-11-11
TW200305433A (en) 2003-11-01
EP0898969A2 (de) 1999-03-03
BR9803232A (pt) 2000-01-11
NZ331529A (en) 1999-03-29
CN1211449A (zh) 1999-03-24
US20020058046A1 (en) 2002-05-16
AR016396A1 (es) 2001-07-04
EP0898969A3 (de) 2001-02-07
EP1477184A3 (de) 2006-04-12
AU8188498A (en) 1999-03-11
JP3049016B2 (ja) 2000-06-05
ZA987662B (en) 2000-02-25
DK0898969T3 (da) 2005-01-17
EP0898969B1 (de) 2004-09-29
PT898969E (pt) 2005-01-31
AU764455B2 (en) 2003-08-21
TWI228419B (en) 2005-03-01
JPH11130683A (ja) 1999-05-18

Similar Documents

Publication Publication Date Title
NO20003303D0 (no) Vaksine
ID22500A (id) Turunan sulfonamida
ID24430A (id) Turunan-turunan benzamidina
DE69831181D1 (de) Positionsbestimmung
DE19810476B4 (de) Laryngomaske
ATA93198A (de) Fluoxetinpellets
DE69834521D1 (de) Löthöckererzeugung
ID23173A (id) Turunan pirol trisiklik atau pirazol
DE69829893D1 (de) Sterilizationsindikator
NO20006191D0 (no) Vaksine
FI974590A0 (fi) Viabestaemningsfoerfarande och- system
ATE277631T1 (de) Neospora impstoff
BR9801805A (pt) Dioxacicloalcan-8-ona
IS5694A (is) Bóluefni
ATA111897A (de) Kimme
NO993633D0 (no) 5-Aroylnaftalen-Derivater
ATE236897T1 (de) 3-benzylpiperidine
ATA112597A (de) Snowboard - bindung
ATA86797A (de) Verschleissschuh
DE29701531U1 (de) Säschar
ATA46498A (de) Kunststoffgleitbahn
BR9701194A (pt) Hidrociclo
DE29712115U1 (de) Aufständerung
DE29717926U1 (de) Zeichenhilfe
ATE421585T1 (de) Motlinhomologe

Legal Events

Date Code Title Description
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee